Quick facts
- Class
- Calcium-regulating peptide hormone
- Brand names
- Miacalcin, Fortical (salmon calcitonin)
- Approved for
- Osteoporosis, Paget's disease, hypercalcemia
- Administration
- Nasal spray or injection
- Status
- FDA-approved, prescription-only
Key takeaways
- Calcitonin is a calcium-lowering hormone, most often used in the more potent salmon form.
- It works mainly by inhibiting osteoclasts, slowing the release of calcium from bone.
- It is used for Paget's disease, hypercalcemia, and osteoporosis, though its role has narrowed.
- Its anti-fracture evidence in osteoporosis is relatively weak compared with other treatments.
- A possible cancer signal with long-term use has led to caution and restrictions in some regions.
Overview
Calcitonin is a hormone that helps lower the level of calcium in the blood. The form used medically is most often salmon calcitonin, marketed under names such as Miacalcin and Fortical, because the salmon version is more potent in humans than the calcitonin the human body naturally produces. It is available as an injection and as a nasal spray.
It has been used for several conditions related to bone and calcium metabolism, including postmenopausal osteoporosis, Paget's disease of bone, and high blood calcium levels known as hypercalcemia. Its role in some of these uses has narrowed over time as other therapies have emerged.
Calcitonin occupies an interesting place in medicine: it is a long-known hormone with a clear biological action, yet its clinical value relative to newer treatments has been reassessed in recent decades. Understanding both its mechanism and its limitations is important for an honest picture of where it fits.
How it works
Calcitonin's main action is to reduce blood calcium, and it does this largely by acting on bone. It binds to receptors on osteoclasts, the cells responsible for breaking down bone tissue. By inhibiting osteoclast activity, calcitonin slows the release of calcium from bone into the bloodstream.
It also influences the kidneys, where it can increase the excretion of calcium in the urine. Together, these effects lower circulating calcium levels, which is the basis for its use in hypercalcemia and in conditions involving excessive bone turnover such as Paget's disease.
In a broad sense, calcitonin acts as a counterbalance to parathyroid hormone, which raises blood calcium. While the body's own calcitonin plays a relatively modest role in everyday calcium regulation, the pharmacological doses used in treatment produce a more pronounced suppression of bone breakdown, at least over the shorter term.
Clinical evidence
The clinical evidence for calcitonin varies by indication. In hypercalcemia and in Paget's disease, it has a recognized role in reducing calcium levels and curbing excessive bone turnover, though other agents are often preferred. For acute pain associated with certain vertebral fractures, calcitonin has sometimes been used, though evidence here is mixed.
For postmenopausal osteoporosis, the picture is more cautious. Compared with other osteoporosis treatments, calcitonin's ability to reduce fracture risk is considered relatively weak, and this comparatively modest anti-fracture evidence has limited its standing as a first-line option.
A significant safety consideration emerged from analyses suggesting a possible small increase in cancer risk associated with long-term calcitonin use. This signal prompted regulatory reviews and contributed to restrictions on prolonged use in some regions. The evidence is debated and not fully settled, but it weighs meaningfully against extended treatment and reflects the importance of honest risk framing.
Dosing & side effects
This article does not provide dosing instructions. Calcitonin is a prescription medication used under medical supervision, available as a nasal spray or injection, with the appropriate form and use determined by a healthcare provider based on the condition being treated.
Common side effects depend on the route. The nasal spray can cause nasal irritation, dryness, or nosebleeds, while injections may cause nausea, flushing, and injection-site reactions. Allergic reactions are possible, since the commonly used form is derived from a salmon protein.
The most consequential safety concern is the possible association between long-term use and a small increase in cancer risk. Because of this, guidance in some regions favors limiting the duration of treatment and reserving calcitonin for situations where its benefits clearly outweigh the risks. These are decisions for a qualified clinician, not for self-directed use.
Legal status
Calcitonin is a prescription medication and has been approved by regulatory agencies, including the U.S. Food and Drug Administration, for indications such as Paget's disease, hypercalcemia, and postmenopausal osteoporosis. It is obtained through pharmacies with a prescription from a licensed provider.
Its regulatory standing has evolved in response to safety reviews. The possible cancer signal associated with long-term use led some regulators, particularly in Europe, to restrict or reassess certain uses, especially the long-term treatment of osteoporosis. Availability of specific products has also changed over time.
Because approvals, restrictions, and product availability differ by country and continue to be updated, anyone considering calcitonin should rely on current prescribing information and the guidance of a qualified healthcare professional rather than on general summaries.
Frequently asked questions
Why is salmon calcitonin used instead of human calcitonin?
Salmon calcitonin is more potent in the human body than the calcitonin humans naturally produce, which makes it the preferred form for medical use.
How does calcitonin lower blood calcium?
It mainly inhibits osteoclasts, the cells that break down bone, reducing the release of calcium from bone. It can also increase calcium excretion by the kidneys.
Is calcitonin a strong treatment for osteoporosis?
Its anti-fracture evidence is considered relatively weak compared with other osteoporosis medications, so it is generally not a first-line choice for that condition.
What is the concern about long-term use?
Analyses suggested a possible small increase in cancer risk with prolonged use. This led to regulatory reviews and restrictions on long-term use in some regions, though the evidence is debated.
Is calcitonin available over the counter?
No. It is a prescription medication used under medical supervision, available as a nasal spray or injection through a licensed provider.
References
Each source links to its original record — peer-reviewed studies, regulator pages, or reference texts, labelled by type. We summarize findings neutrally; a citation is a reference, not an endorsement, and not a claim that its authors reviewed this page.
- Muñoz-Torres M, Alonso G, Raya MP. Calcitonin therapy in osteoporosis. Treat Endocrinol. 2004. Peer-reviewed study
- Ringe JD. [Calcitonin in the prevention and therapy of osteoporosis]. Ther Umsch. 1991. Peer-reviewed study
- Silverman SL. Calcitonin. Endocrinol Metab Clin North Am. 2003. Peer-reviewed study
- Silverman SL. Calcitonin. Am J Med Sci. 1997. Peer-reviewed study
- Neumüller J, Lang-Illievich K, Brenna CTA, et al. Calcitonin in the Treatment of Phantom Limb Pain: A Systematic Review. CNS Drugs. 2023. Peer-reviewed study
- Reginster JY. [Calcitonin]. Rev Med Liege. 1996. Peer-reviewed study